Drug Class
EGFR tyrosine kinase inhibitor
Type
ingredient
Active Ingredient
erlotinib
📋Overview
Erlotinib is a targeted cancer therapy that works by inhibiting the activity of specific proteins involved in cell growth and division. It is most commonly associated with the treatment of certain types of non-small cell lung cancer and pancreatic cancer. Erlotinib is designed to interfere with signals that promote tumor growth, particularly in cancers with specific genetic mutations. Its use is often determined by the molecular characteristics of the tumor.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Erlotinib
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.